Correlation Between SAB Biotherapeutics and Virpax Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and Virpax Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and Virpax Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SAB Biotherapeutics and Virpax Pharmaceuticals, you can compare the effects of market volatilities on SAB Biotherapeutics and Virpax Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of Virpax Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and Virpax Pharmaceuticals.
Diversification Opportunities for SAB Biotherapeutics and Virpax Pharmaceuticals
-0.43 | Correlation Coefficient |
Very good diversification
The 3 months correlation between SAB and Virpax is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and Virpax Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virpax Pharmaceuticals and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with Virpax Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virpax Pharmaceuticals has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and Virpax Pharmaceuticals go up and down completely randomly.
Pair Corralation between SAB Biotherapeutics and Virpax Pharmaceuticals
Assuming the 90 days horizon SAB Biotherapeutics is expected to generate 4.21 times more return on investment than Virpax Pharmaceuticals. However, SAB Biotherapeutics is 4.21 times more volatile than Virpax Pharmaceuticals. It trades about 0.14 of its potential returns per unit of risk. Virpax Pharmaceuticals is currently generating about 0.0 per unit of risk. If you would invest 10.00 in SAB Biotherapeutics on October 20, 2024 and sell it today you would earn a total of 1.00 from holding SAB Biotherapeutics or generate 10.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
SAB Biotherapeutics vs. Virpax Pharmaceuticals
Performance |
| Timeline |
| SAB Biotherapeutics |
| Virpax Pharmaceuticals |
SAB Biotherapeutics and Virpax Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with SAB Biotherapeutics and Virpax Pharmaceuticals
The main advantage of trading using opposite SAB Biotherapeutics and Virpax Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, Virpax Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virpax Pharmaceuticals will offset losses from the drop in Virpax Pharmaceuticals' long position.| SAB Biotherapeutics vs. SAB Biotherapeutics | SAB Biotherapeutics vs. Jasper Therapeutics | SAB Biotherapeutics vs. NRx Pharmaceuticals | SAB Biotherapeutics vs. Surrozen Warrant |
| Virpax Pharmaceuticals vs. Revelation Biosciences | Virpax Pharmaceuticals vs. Palisade Bio | Virpax Pharmaceuticals vs. Virax Biolabs Group | Virpax Pharmaceuticals vs. Quoin Pharmaceuticals Ltd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| CEOs Directory Screen CEOs from public companies around the world |